Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1982 Aug;58(682):493–495. doi: 10.1136/pgmj.58.682.493

Clinical and biochemical effects of parachlorophenylalanine in a patient with the carcinoid syndrome

N D S Bax, H F Woods, A J M Boulton, A R Green
PMCID: PMC2426536  PMID: 6215640

Abstract

The clinical and biochemical features of a patient with flushing and severe diarrhoea due to the carcinoid syndrome are described. The patient had a paradoxical response to the tryptophan hydroxylase inhibitor parachlorophenylalanine with complete abolition of flushing and no effect on the diarrhoea. Treatment with this drug was limited by adverse effects.

Full text

PDF
493

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DAVIS R. B., ROSENBERG J. C. Carcinoid syndrome associated with hyperserotoninemia and normal 5-hydroxyindoleacetic acid excretion. Am J Med. 1961 Jan;30:167–174. doi: 10.1016/0002-9343(61)90072-9. [DOI] [PubMed] [Google Scholar]
  2. Denckla W. D., Dewey H. K. The determination of tryptophan in plasma, liver, and urine. J Lab Clin Med. 1967 Jan;69(1):160–169. [PubMed] [Google Scholar]
  3. Engelman K., Lovenberg W., Sjoerdsma A. Inhibition of serotonin synthesis by para-chlorophenylalanine in patients with the carcinoid syndrome. N Engl J Med. 1967 Nov 23;277(21):1103–1108. doi: 10.1056/NEJM196711232772101. [DOI] [PubMed] [Google Scholar]
  4. Green A. R., Aronson J. K., Curzon G., Woods H. F. Metabolism of an oral tryptophan load. I: Effects of dose and pretreatment with tryptophan. Br J Clin Pharmacol. 1980 Dec;10(6):603–610. doi: 10.1111/j.1365-2125.1980.tb00516.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kaplan E. L., Sizemore G. W., Peskin G. W., Jaffe B. M. Humoral similarities of carcinoid tumors and medullary carcinomas of the thyroid. Surgery. 1973 Jul;74(1):21–29. [PubMed] [Google Scholar]
  6. OATES J. A., MELMON K., SJOERDSMA A., GILLESPIE L., MASON D. T. RELEASE OF A KININ PEPTIDE IN THE CARCINOID SYNDROME. Lancet. 1964 Mar 7;1(7332):514–517. doi: 10.1016/s0140-6736(64)92907-1. [DOI] [PubMed] [Google Scholar]
  7. PAGE I. H., MCCUBBIN J. W. The variable arterial pressure response to serotonin in laboratory animals and man. Circ Res. 1953 Jul;1(4):354–362. doi: 10.1161/01.res.1.4.354. [DOI] [PubMed] [Google Scholar]
  8. SCHNECKLOTH R., PAGE I. H., DEL GRECO F., CORCORAN A. C. Effects of serotonin antagonists in normal subjects and patients with carcinoid tumors. Circulation. 1957 Oct;16(4):523–532. doi: 10.1161/01.cir.16.4.523. [DOI] [PubMed] [Google Scholar]
  9. SMITH A. D., REES J. R., TONKIN R. D., ELLIS H. CARCINOID DISEASE: AN EVER-WIDENING SPECTRUM? Postgrad Med J. 1964 Jun;40:346–349. doi: 10.1136/pgmj.40.464.346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Sandler M., Karim S. M., Williams E. D. Prostaglandins in amine-peptide-secreting tumours. Lancet. 1968 Nov 16;2(7577):1053–1054. doi: 10.1016/s0140-6736(68)91528-6. [DOI] [PubMed] [Google Scholar]
  11. Sicuteri F., Anselmi B., Del Bianco P. L. 5-hydroxytryptamine supersensitivity as a new theory of headache and central pain: a clinical pharmacological approach with p-chlorophenylalanine. Psychopharmacologia. 1973;29(4):347–356. doi: 10.1007/BF00429282. [DOI] [PubMed] [Google Scholar]
  12. UDENFRIEND S., WEISSBACH H., BRODIE B. B. Assay of serotonin and related metabolites, enzymes, and drugs. Methods Biochem Anal. 1958;6:95–130. doi: 10.1002/9780470110225.ch5. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES